Tight control of proteinuria in newly diagnosed lupus nephritis The last 3 years have been exciting times in the field of lupus nephritis (LN) with two new licensed therapies, belimumab (BAFF-inhibitor) and voclosporin (calcineurin-inhibitor). https://t.co/InkX6I7qUm https://t.co/U1M1DtF8Id